https://doi.org/10.1016/s0140-6736(18)32261-x
M
Morten Schou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
357
Papers
12.5K
Citations
48
h-index
136
i10-index
Morten Schou is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Diabetes Treatment and Management. The author has an h-index of 48, co-authored 304 publications.
ORCID: 0000-0002-4271-2466Papers by this author
worksAlbiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
2018 · The Lancet · 1,728 citations
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
2023 · European Heart Journal · 1,301 citations
https://doi.org/10.1093/eurheartj/ehad192
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
2022 · Nature Medicine · 814 citations
https://doi.org/10.1038/s41591-021-01659-1
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
2024 · New England Journal of Medicine · 581 citations
https://doi.org/10.1056/nejmoa2407107
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
2024 · New England Journal of Medicine · 547 citations
https://doi.org/10.1056/nejmoa2313917
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
2016 · European Journal of Heart Failure · 533 citations
https://doi.org/10.1002/ejhf.657
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat